Hansteen bosses increase stakes
Ian Watson and Morgan Jones, joint chief executives of European real estate investment firm Hansteen, have each bought 100,000 shares in the company at 103p each.
They each now own 2.7m shares, or 1.51%, of the company.
Hansteen invests in industrial properties in continental Europe, which it says have higher yields, cheaper financing costs and better opportunity for value improvement through asset management than UK properties.
The company announced two days ago that it had spent €29m on properties which it said had the potential to accrue over €3m a year in rent.
It added that it intended to make some "opportunistic acquisitions" in the UK in 2008 and 2009.
Top Director Buys
Dolphin Capital Investors (DCI)
Director name: Mr Miltos Kambourides
Amount purchased: 650,000 @ 139.00p
Value: £903,500
Hansteen Holdings (HSTN)
Director name: Mr Morgan Lewis Jones
Amount purchased: 100,000 @ 103.00p
Value: £103,000
Hansteen Holdings (HSTN)
Director name: Mr Ian Richard Watson
Amount purchased: 100,000 @ 103.00p
Value: £103,000
Big Yellow Group (BYG)
Director name: Mr David J White
Amount purchased: 25,000 @ 368.00p
Value: £92,000
Lombard Medical Technologies (LMT)
(Article continues below)Advertisement
Director name: Mr Simon Neathercoat
Amount purchased: 178,571 @ 14.00p
Value: £25,000
Lombard Medical Technologies (LMT)
Director name: Mr Craig Rennie
Amount purchased: 178,571 @ 14.00p
Value: £25,000
DTZ Holdings (DTZ)
Director name: Mr Timothy D Melville-Ross
Amount purchased: 10,000 @ 243.00p
Value: £24,300
Lombard Medical Technologies (LMT)
Director name: Mr Michael Stevens
Amount purchased: 142,857 @ 14.00p
Value: £20,000
Business Post (BPG)
Director name: Mr Guy Buswell
Amount purchased: 8,368 @ 239.00p
Value: £20,000
Conister Trust (CTU)
Director name: Mr Arron A F Banks
Amount purchased: 25,000 @ 79.00p
Value: £19,750
